Related Experiment Video
Updated: Jun 14, 2025

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Isothermal Technologies for HPV Detection: Current Trends and Future Perspectives.
Elda A Flores-Contreras1, Everardo González-González2, Gerardo de Jesús Trujillo-Rodríguez2
1Departamento de Patología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Francisco I. Madero y Dr. E. Aguirre Pequeño s/n, Mitras Centro, Monterrey 64460, Mexico.
Isothermal nucleic acid amplification tests (INAATs) offer a promising alternative for human papillomavirus (HPV) detection. These rapid, field-deployable methods overcome limitations of traditional qPCR for timely HPV diagnosis.
Area of Science:
- Virology
- Molecular Diagnostics
- Public Health
Background:
- Human papillomavirus (HPV) comprises over 200 genotypes, with high-risk types linked to cancers like cervical cancer.
- Current HPV detection methods (cytology, hybrid capture, qPCR) face limitations in timely diagnosis.
- Cervical cancer remains a significant cause of mortality in women globally.
Purpose of the Study:
- To review isothermal nucleic acid amplification tests (INAATs) for HPV detection.
- To analyze INAAT characteristics: genotypes, targets, LOD, methods, and time.
- To discuss FDA-approved INAATs and challenges for widespread implementation.
Main Methods:
- Literature review of INAATs for HPV detection.
- Analysis of key performance metrics: HPV genotypes, gene targets, limit of detection (LOD).
- Evaluation of detection methodologies, time, and market-approved tests.
Main Results:
- INAATs provide advantages over qPCR, including reduced need for specialized labs and equipment.
- Specific INAATs show potential for rapid and sensitive HPV detection.
- A range of INAATs are being developed and evaluated for clinical use.
Conclusions:
- INAATs present a viable alternative for timely and accessible HPV detection.
- Addressing implementation challenges is crucial for leveraging INAATs in underserved areas.
- Further development and validation of INAATs can improve cervical cancer screening and prevention strategies.
More Related Videos
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Related Concept Videos
Real Time RT-PCR
The real-time quantification of the number of amplified products is...
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
FISH - Fluorescent In-situ Hybridization